Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989.
Loey Lung-Yi MakChristine I WooddellOliver LenzThomas SchluepJames HamiltonHeather L DavisXianhua MaoWai Kay SetoMichael BiermerMan Fung YuenPublished in: Gut (2024)
Short-duration siRNA treatment suppressed HBsAg expression with a prolonged effect for up to 6 years in some participants.